CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocri...
Phase 3
Roma, RM, Italy and 73 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Rome, Italy and 71 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Roma, Italy and 43 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Rome, Italy and 145 other locations
to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...
Phase 1, Phase 2
Roma, Italy and 46 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Roma, Lazio, Italy and 44 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Roma, Lazio, Italy and 44 other locations
of trastuzumab + Alpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously treated HER2+ Advanced Breast...
Phase 3
Roma, Italy and 105 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Roma, Lazio, Italy and 446 other locations
This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from particip ...
Phase 4
Rome, Lazio, Italy and 24 other locations
Clinical trials
Research sites
Resources
Legal